Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial
Abstract Background Uncontrolled active rheumatoid arthritis can lead to increasing disability and reduced quality of life over time. ‘Treating to target’ has been shown to be effective in active established disease and also in early disease. However, there is a lack of nationally agreed treatment p...
Main Authors: | Naomi H. Martin, Fowzia Ibrahim, Brian Tom, James Galloway, Allan Wailoo, Jonathan Tosh, Heidi Lempp, Louise Prothero, Sofia Georgopoulou, Jackie Sturt, David L. Scott, On behalf of TITRATE Programme Investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-017-2330-8 |
Similar Items
-
Intensive management for moderate rheumatoid arthritis: a qualitative study of patients’ and practitioners’ views
by: Louise Prothero, et al.
Published: (2019-03-01) -
Intensive therapy and remissions in rheumatoid arthritis: a systematic review
by: Catherine D. Hughes, et al.
Published: (2018-10-01) -
Intensive therapy for moderate established rheumatoid arthritis: the TITRATE research programme
by: David L Scott, et al.
Published: (2021-08-01) -
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours – EURO EWING 2012 Protocol
by: Jennifer Anderton, et al.
Published: (2020-01-01) -
The value of large-scale randomised control trials in system-wide improvement: The case of the Reading Catch-Up Programme
by: Brahm Fleisch, et al.
Published: (2017-02-01)